Christiana Davis

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma”.

Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000974

N/A

0DataRank · unranked

117 citations

Christiana Davis, Charuhas Deshpande, Wei‐Ting Hwang, Seth Jeffries, Alexander C. Huang +4 more

Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.10.017

N/A

0DataRank · unranked

37 citations

Christiana Davis, Wei‐Ting Hwang, Seth Jeffries, Lydia Frenzel Sulyok, Melina E. Marmarelis +10 more

Gene signature of antigen processing and presentation machinery (APM) as highly predictive of response to checkpoint blockade in lung cancer and melanoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3121

N/A

0DataRank · unranked

2 citations

Christiana Davis, Wei‐Ting Hwang, Charuhas Deshpande, Seth Jeffries, Corey J. Langer +2 more

Long-term follow-up of “adjuvant” pembrolizumab following locally ablative therapy for oligometastatic non-small cell lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9061

N/A

0DataRank · unranked

0 citations

Christiana Davis, Christine Ciunci, Charu Aggarwal, Tracey L. Evans, Evan Alley +4 more

Neoadjuvant intratumoral immune stimulation using gene-mediated cytotoxic immunotherapy for resectable non−small cell lung cancer: 5-Year outcomes

JTCVS Open(2025)10.1016/j.xjon.2025.10.032

N/A

0DataRank · unranked

1 citations

David Rekhtman, Ella Eisinger, Emma Niemeyer, Christiana Davis, Andrew Haas +10 more